Diagnostic Specialty Antibodies Market

Diagnostic Specialty Antibodies Market (Antibody Type: Monoclonal Antibodies, Polyclonal Antibodies, and Recombinant Polyclonal Antibodies) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2023-2031

Diagnostic Specialty Antibodies Market Outlook 2031

  • The global industry was valued at US$ 26.1 Bn in 2022
  • It is expected to grow at a CAGR of 5.4% from 2023 to 2031 and reach US$ 41.4 Bn by the end of 2031

Analyst Viewpoint

Rise in prevalence of infectious and chronic diseases is a prominent factor boosting the global diagnostic specialty antibodies market growth. Diagnostic biomarker antibodies are broadly used in the diagnosis of chronic and infectious diseases.

They can also be effectively used in the detection of pregnancy and monitoring the action of drugs in the body. Advancements in DNA-based technologies and diagnostics are also augmenting the diagnostic specialty antibodies market size.

Companies operating in the global diagnostic specialty antibodies are exploring the process of quantification of protein abundance on single cells by using split-pool sequencing on DNA-barcoded antibodies for various diagnostic applications.

In line with the latest diagnostic specialty antibodies market trends, they are further exploring the usage of biosensors, which are efficient than polymerase chain reaction (PCR) and enzyme-linked immunosorbent assay (ELISA).

Market Introduction

Antibody refers to a blood protein produced as a response to a specific antigen. Advancements in recombinant DNA technology have facilitated the creation of diagnostic specialty antibodies that are used in imaging and therapeutic applications. Diagnostic specialty antibodies are also used in general medical practice.

Increase in prevalence of infectious and chronic diseases is driving the demand for diagnostic kits and biological drugs. Several biopharmaceutical and biotechnology companies are offering in-vitro diagnostics antibodies to cater to the requirements of the immunoassay reagents market.

However, certain variables are likely to negatively influence the future analysis and development trends in diagnostic specialty antibodies market.

One of these pertains to the quantity of antibody that needs to be present in body fluids or blood. Any discrepancy in this quantity may give incorrect results. This is anticipated to hamper the growth of the diagnostic specialty antibodies industry during the forecast period.

Attribute Detail
Market Drivers
  • Increase in Incidence of Chronic and Infectious Diseases
  • Advancements in DNA-based Technologies and Diagnostics

Rise in Prevalence of Chronic and Infectious Diseases Driving Diagnostic Specialty Antibodies Market

As per the National Institutes of Health, out of the population aged 50 and above across the globe, the percentage with minimum one chronic disease is expected to increase by 99.5% between 2020 and 2050.

The National Institutes of Health further states that the percentage of people suffering from multimorbidity is estimated to rise to 91.2% between 2020 and 2050.

Infectious diseases are also proving to be one of the major threats to health. The recent examples include SARS, Ebola virus, and AIDS.

Diagnostic specialty antibodies enable the identification of emerging disease hotspots. This helps in ascertaining health risks at an earlier stage and preparing containment strategies pertaining to these risks.

Of late, re-emergence of certain diseases is being observed due to the acquired resistance of pathogens to antimicrobial medications such as antibiotics. Rise in need to exercise control over infectious and chronic diseases is a key factor that is bolstering the diagnostic specialty antibodies industry.

Advancements in DNA-based Technologies and Diagnostics Augmenting Diagnostic Specialty Antibodies Market Forecast and Growth Insights

According to an article published by BMC Public Health, a scientific journal published by BioMed Central, immunohistochemistry (IHC) using polyclonal and monoclonal antibodies is useful to detect pathogen antigens in fixed tissues.

As per BMC Public Health, this complements the direct diagnosis of infectious diseases by PCR and culture on fresh tissues. Immunohistochemistry technique that uses anti-p24 monoclonal antibody is also proving useful in detection of HIV in lymph node biopsies of patients suffering from follicular hyperplasia.

As per an article published in April 2021 by Multidisciplinary Digital Publishing Institute (MDPI), a publisher of open-access scientific journals, monoclonal antibodies are among the emerging tools used for the diagnosis of cancer.

Researchers have recently cloned an anti-p16 antibody that may turn out to be a novel valuable tool for diagnosing pathological cancer.

In October 2022, Roche announced the launch of Anti-PRAME (EPR 20330) Rabbit Monoclonal Primary Antibody for identifying PRAME protein expression in tissue samples from those suffering from melanoma. PRAME antibody is used to differentiate between malignant and benign lesions.

Thus, continuous advancements in DNA-based technologies is accelerating the demand for next-generation antibodies for multiplexed diagnostic panels.

Diagnostic Specialty Antibodies Market Regional Highlights

Attribute Detail
Leading Region North America

North America accounted for the largest diagnostic specialty antibodies market share in 2022. The region is projected to maintain its leading position across the globe during the forecast period.

Market expansion in North America can be ascribed to the presence of a well-established healthcare infrastructure in the U.S. Furthermore, the country witnessed 1.9 million new cases of cancer in 2021 alone. This is also fostering market development in the region.

Europe and Asia Pacific are projected to record considerable market progress in the near future owing to the rise in awareness about need for specialized antibodies for neurological disorder diagnostics. As per the National Institutes of Health, stroke, headache, and dementia are rampant in the European Union.

Analysis of Key Players

Companies operating in the global diagnostic specialty antibodies landscape are engaged in mergers and acquisitions to strengthen their industry position.

In October 2022, Thermo Fisher announced that it had signed a definitive agreement to acquire The Binding Site Group with the objective of improving diagnosis as well as management of immune system disorders and blood cancers.

Abcam plc, F. Hoffmann-La Roche Ltd., Abbott Laboratories, Sanofi, Bio-Rad Laboratories, Inc., Boehringer Ingelheim International GmbH, Agilent Technologies, Inc., and Aytu BioScience, Inc. have been profiled in the diagnostic specialty antibodies market analysis report based on parameters such as company overview, business strategies, financial overview, product portfolio, and business segments.

Key Developments

  • In February 2022, Abcam plc announced that it had entered into a licensing agreement with Twist Bioscience Corporation. As per the agreement, the former will use the proprietary Twist VHH phage library for discovery and commercialization of antibodies for research and diagnostic applications.
  • In January 2022, Bio-Rad Laboratories, Inc. announced the launch of four inhibitory antibodies specific to pertuzumab (Perjeta). These antibodies inhibit the binding of drug to human epidermal growth factor 2 (HER2), thereby facilitating the development of highly sensitive and selective assays that can be used for bioanalysis, diagnosis, and monitoring of biosimilars of pertuzumab.

Diagnostic Specialty Antibodies Market Snapshot

Attribute Detail
Market Size in 2022 US$ 26.1 Bn
Market Forecast (Value) in 2031 US$ 41.4 Bn
Growth Rate (CAGR) 5.4%
Forecast Period 2023-2031
Historical Data Available for 2017-2021
Quantitative Units US$ Bn for Value
Market Analysis It includes segment analysis as well as regional level analysis. Moreover, qualitative analysis includes drivers, restraints, opportunities, key trends, Porter’s Five Forces analysis, value chain analysis, and key trend analysis.
Competition Landscape
  • Market share analysis by company (2022)
  • Company profiles section includes overview, product portfolio, sales footprint, key subsidiaries or distributors, strategy & recent developments, and key financials
Format Electronic (PDF) + Excel
Market Segmentation
  • Antibody Type
    • Monoclonal Antibodies
    • Polyclonal Antibodies
    • Recombinant Polyclonal Antibodies
  • Application
    • Hepatitis Diagnostics
    • Tuberculosis Diagnostics
    • Dengue Diagnostics
    • Oncology Diagnostics
    • HIV Diagnostics
    • Infectious Disease Diagnostics
    • Others
  • End-user
    • Hospitals
    • Diagnostic Laboratories
    • Others
Regions Covered
  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East & Africa
Countries Covered
  • U.S.
  • Canada
  • Germany
  • U.K.
  • France
  • Italy
  • Spain
  • China
  • India
  • Japan
  • Australia & New Zealand
  • Brazil
  • Mexico
  • South Africa
  • GCC
Companies Profiled
  • Abcam plc
  • F. Hoffmann-La Roche Ltd.
  • Abbott Laboratories
  • Sanofi
  • Bio-Rad Laboratories, Inc.
  • Boehringer Ingelheim International GmbH
  • Agilent Technologies, Inc.
  • Aytu BioScience, Inc.
Customization Scope Available Upon Request
Pricing Available Upon Request

Frequently Asked Questions

How big was the global diagnostic specialty antibodies market in 2022?

It was valued at US$ 26.1 Bn in 2022

How is the diagnostic specialty antibodies business expected to grow during the forecast period?

It is projected to grow at a CAGR of 5.4% from 2023 to 2031

What are the key factors driving the demand for diagnostic specialty antibodies?

Increase in incidence of chronic and infectious diseases, and advancements in DNA-based technologies and diagnostics

Which diagnostic specialty antibodies end-user segment held the largest share in 2022?

The hospitals segment accounted for the largest share in 2022

Which region dominated the global diagnostic specialty antibodies landscape in 2022?

North America was the dominant region in 2022

Who are the key players in the diagnostic specialty antibodies industry?

Abcam plc, F. Hoffmann-La Roche Ltd., Abbott Laboratories, Sanofi, Bio-Rad Laboratories, Inc., Boehringer Ingelheim International GmbH, Agilent Technologies, Inc., and Aytu BioScience, Inc.

    1. Preface

        1.1. Market Definition and Scope

        1.2. Market Segmentation

        1.3. Key Research Objectives

        1.4. Research Highlights

    2. Assumptions and Research Methodology

    3. Executive Summary: Global Diagnostic Specialty Antibodies Market

    4. Market Overview

        4.1. Introduction

            4.1.1. Product Definition

            4.1.2. Industry Evolution/Developments

        4.2. Overview

        4.3. Market Dynamics

            4.3.1. Drivers

            4.3.2. Restraints

            4.3.3. Opportunities

        4.4. Global Diagnostic Specialty Antibodies Market Analysis and Forecast, 2017-2031

    5. Key Insights

        5.1. Pipeline Analysis

        5.2. Key Product/Brand Analysis

        5.3. Key Mergers & Acquisitions

        5.4. COVID-19 Pandemic Impact on Industry

    6. Global Diagnostic Specialty Antibodies Market Analysis and Forecast, by Antibody Type

        6.1. Introduction & Definition

        6.2. Key Findings/Developments

        6.3. Market Value Forecast, by Antibody Type, 2017-2031

            6.3.1. Monoclonal Antibodies

            6.3.2. Polyclonal Antibodies

            6.3.3. Recombinant Polyclonal Antibodies

        6.4. Market Attractiveness Analysis, by Antibody Type

    7. Global Diagnostic Specialty Antibodies Market Analysis and Forecast, by Application

        7.1. Introduction & Definition

        7.2. Key Findings/Developments

        7.3. Market Value Forecast, by Application, 2017-2031

            7.3.1. Hepatitis Diagnosis

            7.3.2. Tuberculosis Diagnosis

            7.3.3. Dengue Diagnosis

            7.3.4. Oncology Diagnosis

            7.3.5. HIV Diagnosis

            7.3.6. Infectious Disease Diagnosis

            7.3.7. Others

        7.4. Market Attractiveness Analysis, by Application

    8. Global Diagnostic Specialty Antibodies Market Analysis and Forecast, by End-user

        8.1. Introduction & Definition

        8.2. Key Findings/Developments

        8.3. Market Value Forecast, by End-user, 2017-2031

            8.3.1. Hospitals

            8.3.2. Diagnostic Laboratories

            8.3.3. Others

        8.4. Market Attractiveness Analysis, by Application

    9. Global Diagnostic Specialty Antibodies Market Analysis and Forecast, by Region

        9.1. Key Findings

        9.2. Market Value Forecast, by Region, 2017-2031

            9.2.1. North America

            9.2.2. Europe

            9.2.3. Asia Pacific

            9.2.4. Latin America

            9.2.5. Middle East & Africa

        9.3. Market Attractiveness Analysis, by Region

    10. North America Diagnostic Specialty Antibodies Market Analysis and Forecast

        10.1. Introduction

        10.2. Key Findings

        10.3. Market Value Forecast, by Antibody Type, 2017-2031

            10.3.1. Monoclonal Antibodies

            10.3.2. Polyclonal Antibodies

            10.3.3. Recombinant Polyclonal Antibodies

        10.4. Market Value Forecast, by Application, 2017-2031

            10.4.1. Hepatitis Diagnosis

            10.4.2. Tuberculosis Diagnosis

            10.4.3. Dengue Diagnosis

            10.4.4. Oncology Diagnosis

            10.4.5. HIV Diagnosis

            10.4.6. Infectious Disease Diagnosis

            10.4.7. Others

        10.5. Market Value Forecast, by End-user, 2017-2031

            10.5.1. Hospitals

            10.5.2. Diagnostic Laboratories

            10.5.3. Others

        10.6. Market Value Forecast, by Country, 2017-2031

            10.6.1. U.S.

            10.6.2. Canada

        10.7. Market Attractiveness Analysis

            10.7.1. By Antibody Type

            10.7.2. By Application

            10.7.3. By End-user

            10.7.4. By Country

    11. Europe Diagnostic Specialty Antibodies Market Analysis and Forecast

        11.1. Introduction

        11.2. Key Findings

        11.3. Market Value Forecast, by Antibody Type, 2017-2031

            11.3.1. Monoclonal Antibodies

            11.3.2. Polyclonal Antibodies

            11.3.3. Recombinant Polyclonal Antibodies

        11.4. Market Value Forecast, by Application, 2017-2031

            11.4.1. Hepatitis Diagnosis

            11.4.2. Tuberculosis Diagnosis

            11.4.3. Dengue Diagnosis

            11.4.4. Oncology Diagnosis

            11.4.5. HIV Diagnosis

            11.4.6. Infectious Disease Diagnosis

            11.4.7. Others

        11.5. Market Value Forecast, by End-user, 2017-2031

            11.5.1. Hospitals

            11.5.2. Diagnostic Laboratories

            11.5.3. Others

        11.6. Market Value Forecast, by Country/Sub-region, 2017-2031

            11.6.1. Germany

            11.6.2. U.K.

            11.6.3. France

            11.6.4. Italy

            11.6.5. Spain

            11.6.6. Rest of Europe

        11.7. Market Attractiveness Analysis

            11.7.1. By Antibody Type

            11.7.2. By Application

            11.7.3. By End-user

            11.7.4. By Country/Sub-region

    12. Asia Pacific Diagnostic Specialty Antibodies Market Analysis and Forecast

        12.1. Introduction

        12.2. Key Findings

        12.3. Market Value Forecast, by Antibody Type, 2017-2031

            12.3.1. Monoclonal Antibodies

            12.3.2. Polyclonal Antibodies

            12.3.3. Recombinant Polyclonal Antibodies

        12.4. Market Value Forecast, by Application, 2017-2031

            12.4.1. Hepatitis Diagnosis

            12.4.2. Tuberculosis Diagnosis

            12.4.3. Dengue Diagnosis

            12.4.4. Oncology Diagnosis

            12.4.5. HIV Diagnosis

            12.4.6. Infectious Disease Diagnosis

            12.4.7. Others

        12.5. Market Value Forecast, by End-user, 2017-2031

            12.5.1. Hospitals

            12.5.2. Diagnostic Laboratories

            12.5.3. Others

        12.6. Market Value Forecast, by Country/Sub-region, 2017-2031

            12.6.1. China

            12.6.2. Japan

            12.6.3. India

            12.6.4. Australia & New Zealand

            12.6.5. Rest of Asia Pacific

        12.7. Market Attractiveness Analysis

            12.7.1. By Antibody Type

            12.7.2. By Application

            12.7.3. By End-user

            12.7.4. By Country/Sub-region

    13. Latin America Diagnostic Specialty Antibodies Market Analysis and Forecast

        13.1. Introduction

        13.2. Key Findings

        13.3. Market Value Forecast, by Antibody Type, 2017-2031

            13.3.1. Monoclonal Antibodies

            13.3.2. Polyclonal Antibodies

            13.3.3. Recombinant Polyclonal Antibodies

        13.4. Market Value Forecast, by Application, 2017-2031

            13.4.1. Hepatitis Diagnosis

            13.4.2. Tuberculosis Diagnosis

            13.4.3. Dengue Diagnosis

            13.4.4. Oncology Diagnosis

            13.4.5. HIV Diagnosis

            13.4.6. Infectious Disease Diagnosis

            13.4.7. Others

        13.5. Market Value Forecast, by End-user, 2017-2031

            13.5.1. Hospitals

            13.5.2. Diagnostic Laboratories

            13.5.3. Others

        13.6. Market Value Forecast, by Country/Sub-region, 2017-2031

            13.6.1. Brazil

            13.6.2. Mexico

            13.6.3. Rest of Latin America

        13.7. Market Attractiveness Analysis

            13.7.1. By Antibody Type

            13.7.2. By Application

            13.7.3. By End-user

            13.7.4. By Country/Sub-region

    14. Middle East & Africa Diagnostic Specialty Antibodies Market Analysis and Forecast

        14.1. Introduction

        14.2. Key Findings

        14.3. Market Value Forecast, by Antibody Type, 2017-2031

            14.3.1. Monoclonal Antibodies

            14.3.2. Polyclonal Antibodies

            14.3.3. Recombinant Polyclonal Antibodies

        14.4. Market Value Forecast, by Application, 2017-2031

            14.4.1. Hepatitis Diagnosis

            14.4.2. Tuberculosis Diagnosis

            14.4.3. Dengue Diagnosis

            14.4.4. Oncology Diagnosis

            14.4.5. HIV Diagnosis

            14.4.6. Infectious Disease Diagnosis

            14.4.7. Others

        14.5. Market Value Forecast, by End-user, 2017-2031

            14.5.1. Hospitals

            14.5.2. Diagnostic Laboratories

            14.5.3. Others

        14.6. Market Value Forecast, by Country/Sub-region, 2017-2031

            14.6.1. GCC Countries

            14.6.2. South Africa

            14.6.3. Rest of Middle East & Africa

        14.7. Market Attractiveness Analysis

            14.7.1. By Antibody Type

            14.7.2. By Application

            14.7.3. By End-user

            14.7.4. By Country/Sub-region

    15. Competition Landscape

        15.1. Market Player - Competitive Matrix (by Tier and Size of Companies)

        15.2. Market Share Analysis, by Company (2022)

        15.3. Company Profiles

            15.3.1. Abcam plc

                15.3.1.1. Company Overview

                15.3.1.2. Product Portfolio

                15.3.1.3. SWOT Analysis

                15.3.1.4. Financial Overview

                15.3.1.5. Strategic Overview

            15.3.2. F. Hoffmann-La Roche Ltd.

                15.3.2.1. Company Overview

                15.3.2.2. Product Portfolio

                15.3.2.3. SWOT Analysis

                15.3.2.4. Financial Overview

                15.3.2.5. Strategic Overview

            15.3.3. Abbott Laboratories

                15.3.3.1. Company Overview

                15.3.3.2. Product Portfolio

                15.3.3.3. SWOT Analysis

                15.3.3.4. Financial Overview

                15.3.3.5. Strategic Overview

            15.3.4. Sanofi

                15.3.4.1. Company Overview

                15.3.4.2. Product Portfolio

                15.3.4.3. SWOT Analysis

                15.3.4.4. Financial Overview

                15.3.4.5. Strategic Overview

            15.3.5. Bio-Rad laboratories, Inc.

                15.3.5.1. Company Overview

                15.3.5.2. Product Portfolio

                15.3.5.3. SWOT Analysis

                15.3.5.4. Financial Overview

                15.3.5.5. Strategic Overview

            15.3.6. Boehringer Ingelheim International GmbH

                15.3.6.1. Company Overview

                15.3.6.2. Product Portfolio

                15.3.6.3. SWOT Analysis

                15.3.6.4. Financial Overview

                15.3.6.5. Strategic Overview

            15.3.7. Agilent Technologies, Inc.

                15.3.7.1. Company Overview

                15.3.7.2. Product Portfolio

                15.3.7.3. SWOT Analysis

                15.3.7.4. Financial Overview

                15.3.7.5. Strategic Overview

            15.3.8. Aytu BioScience, Inc.

                15.3.8.1. Company Overview

                15.3.8.2. Product Portfolio

                15.3.8.3. SWOT Analysis

                15.3.8.4. Financial Overview

                15.3.8.5. Strategic Overview

    List of Tables

    Table 01: Global Diagnostic Specialty Antibodies Market Size (US$ Mn) Forecast, by Antibody Type, 2017-2031

    Table 02: Global Diagnostic Specialty Antibodies Market Size (US$ Mn) Forecast, by Application, 2017-2031

    Table 03: Global Diagnostic Specialty Antibodies Market Size (US$ Mn) Forecast, by End-user, 2017-2031

    Table 04: Global Diagnostic Specialty Antibodies Market Size (US$ Mn) Forecast, by Region, 2017-2031

    Table 05: North America Diagnostic Specialty Antibodies Market Size (US$ Mn) Forecast, by Country, 2017-2031

    Table 06: North America Diagnostic Specialty Antibodies Market Size (US$ Mn) Forecast, by Antibody Type, 2017-2031

    Table 07: North America Diagnostic Specialty Antibodies Market Size (US$ Mn) Forecast, by Application, 2017-2031

    Table 08: North America Diagnostic Specialty Antibodies Market Size (US$ Mn) Forecast, by End-user, 2017-2031

    Table 09: Europe Diagnostic Specialty Antibodies Market Size (US$ Mn) Forecast, by Country/Sub-region, 2017-2031

    Table 10: Europe Diagnostic Specialty Antibodies Market Size (US$ Mn) Forecast, by Antibody Type, 2017-2031

    Table 11: Europe Diagnostic Specialty Antibodies Market Size (US$ Mn) Forecast, by Application, 2017-2031

    Table 12: Europe Diagnostic Specialty Antibodies Market Size (US$ Mn) Forecast, by End-user, 2017-2031

    Table 13: Asia Pacific Diagnostic Specialty Antibodies Market Size (US$ Mn) Forecast, by Country/Sub-region, 2017-2031

    Table 14: Asia Pacific Diagnostic Specialty Antibodies Market Size (US$ Mn) Forecast, by Antibody Type, 2017-2031

    Table 15: Asia Pacific Diagnostic Specialty Antibodies Market Size (US$ Mn) Forecast, by Application, 2017-2031

    Table 16: Asia Pacific Diagnostic Specialty Antibodies Market Size (US$ Mn) Forecast, by End-user, 2017-2031

    Table 17: Latin America Diagnostic Specialty Antibodies Market Size (US$ Mn) Forecast, by Country/Sub-region, 2017-2031

    Table 18: Latin America Diagnostic Specialty Antibodies Market Size (US$ Mn) Forecast, by Antibody Type, 2017-2031

    Table 19: Latin America Diagnostic Specialty Antibodies Market Size (US$ Mn) Forecast, by Application, 2017-2031

    Table 20: Latin America Diagnostic Specialty Antibodies Market Size (US$ Mn) Forecast, by End-user, 2017-2031

    Table 21: Middle East & Africa Diagnostic Specialty Antibodies Market Size (US$ Mn) Forecast, by Country/Sub-region, 2017-2031

    Table 22: Middle East & Africa Diagnostic Specialty Antibodies Market Size (US$ Mn) Forecast, by Antibody Type, 2017-2031

    Table 23: Middle East & Africa Diagnostic Specialty Antibodies Market Size (US$ Mn) Forecast, by Application, 2017-2031

    Table 24: Middle East & Africa Diagnostic Specialty Antibodies Market Size (US$ Mn) Forecast, by End-user, 2017-2031

    List of Figures

    Figure 01: Global Diagnostic Specialty Antibodies Market Size (US$ Mn) and Distribution (%), by Region, 2022 and 2031

    Figure 02: Global Diagnostic Specialty Antibodies Market Revenue (US$ Mn), by Antibody Type, 2022

    Figure 03: Global Diagnostic Specialty Antibodies Market Value Share, by Antibody Type, 2022

    Figure 04: Global Diagnostic Specialty Antibodies Market Revenue (US$ Mn), by Application, 2022

    Figure 05: Global Diagnostic Specialty Antibodies Market Value Share, by Application, 2022

    Figure 06: Global Diagnostic Specialty Antibodies Market Revenue (US$ Mn), by End-user, 2022

    Figure 07: Global Diagnostic Specialty Antibodies Market Value Share, by End-user, 2022

    Figure 08: Global Diagnostic Specialty Antibodies Market Value Share, by Region, 2022

    Figure 09: Global Diagnostic Specialty Antibodies Market Value (US$ Mn) Forecast, 2023-2031

    Figure 10: Global Diagnostic Specialty Antibodies Market Value Share Analysis, by Antibody Type, 2022 and 2031

    Figure 11: Global Diagnostic Specialty Antibodies Market Attractiveness Analysis, by Antibody Type, 2023-2031

    Figure 12: Global Diagnostic Specialty Antibodies Market Value Share Analysis, by Application, 2022 and 2031

    Figure 13: Global Diagnostic Specialty Antibodies Market Attractiveness Analysis, by Application, 2023-2031

    Figure 14: Global Diagnostic Specialty Antibodies Market Value Share Analysis, by End-user, 2022 and 2031

    Figure 15: Global Diagnostic Specialty Antibodies Market Attractiveness Analysis, by End-user, 2023-2031

    Figure 16: Global Diagnostic Specialty Antibodies Market Value Share Analysis, by Region, 2022 and 2031

    Figure 17: Global Diagnostic Specialty Antibodies Market Attractiveness Analysis, by Region, 2023-2031

    Figure 18: North America Diagnostic Specialty Antibodies Market Value (US$ Mn) Forecast and Y-o-Y Growth (%), 2017-2031

    Figure 19: North America Diagnostic Specialty Antibodies Market Attractiveness Analysis, by Country, 2023-2031

    Figure 20: North America Diagnostic Specialty Antibodies Market Value Share Analysis, by Country, 2022 and 2031

    Figure 21: North America Diagnostic Specialty Antibodies Market Value Share Analysis, by Antibody Type, 2022 and 2031

    Figure 22: North America Diagnostic Specialty Antibodies Market Value Share Analysis, by Application, 2022 and 2031

    Figure 23: North America Diagnostic Specialty Antibodies Market Value Share Analysis, by End-user, 2022 and 2031

    Figure 24: North America Diagnostic Specialty Antibodies Market Attractiveness Analysis, by Antibody Type, 2023-2031

    Figure 25: North America Diagnostic Specialty Antibodies Market Attractiveness Analysis, by Application, 2023-2031

    Figure 26: North America Diagnostic Specialty Antibodies Market Attractiveness Analysis, by End-user, 2023-2031

    Figure 27: Europe Diagnostic Specialty Antibodies Market Value (US$ Mn) Forecast and Y-o-Y Growth (%), 2017-2031

    Figure 28: Europe Diagnostic Specialty Antibodies Market Attractiveness Analysis, by Country/Sub-region, 2023-2031

    Figure 29: Europe Diagnostic Specialty Antibodies Market Value Share Analysis, by Country/Sub-region, 2022 and 2031

    Figure 30: Europe Diagnostic Specialty Antibodies Market Value Share Analysis, by Antibody Type, 2022 and 2031

    Figure 31: Europe Diagnostic Specialty Antibodies Market Value Share Analysis, by Application, 2022 and 2031

    Figure 32: Europe Diagnostic Specialty Antibodies Market Value Share Analysis, by End-user, 2022 and 2031

    Figure 33: Europe Diagnostic Specialty Antibodies Market Attractiveness Analysis, by Antibody Type, 2023-2031

    Figure 34: Europe Diagnostic Specialty Antibodies Market Attractiveness Analysis, by Application, 2023-2031

    Figure 35: Europe Diagnostic Specialty Antibodies Market Attractiveness Analysis, by End-user, 2023-2031

    Figure 36: Asia Pacific Diagnostic Specialty Antibodies Market Value (US$ Mn) Forecast and Y-o-Y Growth (%), 2017-2031

    Figure 37: Asia Pacific Diagnostic Specialty Antibodies Market Attractiveness Analysis, by Country/Sub-region, 2023-2031

    Figure 38: Asia Pacific Diagnostic Specialty Antibodies Market Value Share Analysis, by Country/Sub-region, 2022 and 2031

    Figure 39: Asia Pacific Diagnostic Specialty Antibodies Market Value Share Analysis, by Antibody Type, 2022 and 2031

    Figure 40: Asia Pacific Diagnostic Specialty Antibodies Market Value Share Analysis, by Application, 2022 and 2031

    Figure 41: Asia Pacific Diagnostic Specialty Antibodies Market Value Share Analysis, by End-user, 2022 and 2031

    Figure 42: Asia Pacific Diagnostic Specialty Antibodies Market Attractiveness Analysis, by Antibody Type, 2023-2031

    Figure 43: Asia Pacific Diagnostic Specialty Antibodies Market Attractiveness Analysis, by Application, 2023-2031

    Figure 44: Asia Pacific Diagnostic Specialty Antibodies Market Attractiveness Analysis, by End-user, 2023-2031

    Figure 45: Latin America Diagnostic Specialty Antibodies Market Value (US$ Mn) Forecast and Y-o-Y Growth (%), 2017-2031

    Figure 46: Latin America Diagnostic Specialty Antibodies Market Attractiveness Analysis, by Country/Sub-region, 2023-2031

    Figure 47: Latin America Diagnostic Specialty Antibodies Market Value Share Analysis, by Country/Sub-region, 2022 and 2031

    Figure 48: Latin America Diagnostic Specialty Antibodies Market Value Share Analysis, by Antibody Type, 2022 and 2031

    Figure 49: Latin America Diagnostic Specialty Antibodies Market Value Share Analysis, by Application, 2022 and 2031

    Figure 50: Latin America Diagnostic Specialty Antibodies Market Value Share Analysis, by End-user, 2022 and 2031

    Figure 51: Latin America Diagnostic Specialty Antibodies Market Attractiveness Analysis, by Antibody Type, 2023-2031

    Figure 52: Latin America Diagnostic Specialty Antibodies Market Attractiveness Analysis, by Application, 2023-2031

    Figure 53: Latin America Diagnostic Specialty Antibodies Market Attractiveness Analysis, by End-user, 2023-2031

    Figure 54: Middle East & Africa Diagnostic Specialty Antibodies Market Size (US$ Mn) Forecast and Y-o-Y Growth (%), 2017-2031

    Figure 55: Middle East & Africa Diagnostic Specialty Antibodies Market Attractiveness Analysis, by Country/Sub-region, 2023-2031

    Figure 56: Middle East & Africa Diagnostic Specialty Antibodies Market Value Share Analysis, by Country/Sub-region, 2022 and 2031

    Figure 57: Middle East & Africa Diagnostic Specialty Antibodies Market Value Share Analysis, by Antibody Type, 2022 and 2031

    Figure 58: Middle East & Africa Diagnostic Specialty Antibodies Market Value Share Analysis, by Application, 2022 and 2031

    Figure 59: Middle East & Africa Diagnostic Specialty Antibodies Market Value Share Analysis, by End-user, 2022 and 2031

    Figure 60: Middle East & Africa Diagnostic Specialty Antibodies Market Attractiveness Analysis, by Antibody Type, 2023-2031

    Figure 61: Middle East & Africa Diagnostic Specialty Antibodies Market Attractiveness Analysis, by Application, 2023-2031

    Figure 62: Middle East & Africa Diagnostic Specialty Antibodies Market Attractiveness Analysis, by End-user, 2023-2031

Copyright © Transparency Market Research, Inc. All Rights reserved